Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TEVA - FDA OK's Teva's generic Narcan nasal spray for opioid overdose


TEVA - FDA OK's Teva's generic Narcan nasal spray for opioid overdose

  • The FDA grants final approval for Teva Pharmaceutical Industries' (NYSE:TEVA) generic version of Adapt Pharma's NARCAN Nasal Spray (naloxone HCl), an opioid reversal agent designed to be used by someone with no medical training for treating a person who has overdosed.
  • More news on: Teva Pharmaceutical Industries Limited, Emergent BioSolutions Inc., Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Teva Pharmaceutical Industries Limited American Depositary Shares
Stock Symbol: TEVA
Market: NYSE
Website: tevapharm.com

Menu

TEVA TEVA Quote TEVA Short TEVA News TEVA Articles TEVA Message Board
Get TEVA Alerts

News, Short Squeeze, Breakout and More Instantly...